FDA Panel Rules Avastin Unsafe For Breast Cancer Use
All six voting members of the FDA's Oncologic Drugs Advisory Committee concluded that Avastin is unsafe for treating metastatic breast cancer and urged FDA Commissioner Margaret Hamburg to withdraw approval for such usage.
The advisory committee added that approval should not be continued while Genetech conducts additional studies to demonstrate the benefits of using...
Already a subscriber? Click here to login